Part Number : NDC00039-0052-10 | Manufacturer : Sanofi Aventis U S Llc | ||
NSN : 6505-01-187-6585 (6505011876585) | |||
Item Name : Glyburide Tablets Usp | CAGE Code : 24268 | ||
NIIN : 01-187-6585 (011876585) | |||
INC Code : 66764 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC00039005210 |
Thank you for taking an interest in part number NDC00039-0052-10, that of which is listed with the description Glyburide Tablets Usp; Manufactured by Sanofi Aventis U S Llc and listed alongside the NSN 6505011876585, part number NDC00039-0052-10 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC00039-0052-10 | Manufacturer : Sanofi Aventis U S Llc | ||
NSN Number : 6505-01-187-6585 (6505011876585) | |||
Item Name : Glyburide Tablets Usp | CAGE Code : 24268 | ||
NIIN : 011876585 |
Thank you for taking an interest in part number NDC00039-0052-10, that of which is listed with the description Glyburide Tablets Usp; Manufactured by Sanofi Aventis U S Llc and listed alongside the NSN 6505011876585, part number NDC00039-0052-10 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-187-6585 Item Description: Glyburide Tablets Usp | 6505 | 011876585 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
NDC00039-0052-10 | 2 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS GLYBURIDE ACTIVE INGREDIENT |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DIABETA TABLETS |
FEAT | SPECIAL FEATURES | STORE AT CONTROLLED ROOM TEMPERATURE 59 DEG - 86 DEG F. |
THPE | THERAPEUTIC EQUIVALENT | DIABETA BY HOECHST-ROUSSEL PHARM.,INC. |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote